Altogether, the interactions among LINC01124, miR-1247-5p, and FOXO3 constitute a novel ceRNA pathway in HCC which may serve as a new treatment target in the field of HCC management. The gene discussed is FOXO3; the disease is hepatocellular carcinoma.